3 ms·
"Based on this exposure level, the estimated rate of TTS within 14 days of the second AZD1222 dose was 2.3 per million vaccinees. By comparison, within the same
by _Microft 5y ago
"Based on this exposure level, the estimated rate of TTS within 14 days of the second AZD1222 dose was 2.3 per million vaccinees. By comparison, within the same timeframes, the estimated rate of TTS within 14 days of the first dose was 8.1 per million vaccinees"
If I am not mistaken this means that one is less likely to get thrombosis with thrombocytopenia syndrome (TTS) after the second dose of the AstraZeneca vaccine than one were after the first. Sounds like good news.